Related Experiment Video
Updated: Jan 23, 2026

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
Blocking Wnt as a therapeutic target in mice model of skin cancer
Abdullah Alyoussef1, Medhat Taha2
1Department of Internal Medicine (Dermatology), Faculty of Medicine, University of Tabuk, Tabuk, 71471, Saudi Arabia. aalyoussef@ut.edu.sa.
Abstract:
Wnt pathway plays an important role in controlling metabolism in cancer cells. It acts as positive modulator for both cell inflammation, through activation of NFκB, and fibrosis, through activation of TGF-β. Therefore, the aim of this study is to investigate the therapeutic effects of blocking Wnt pathway by IWP12 on skin cancer by studying its effects on skin cancer-induced inflammation and fibrosis in a mice model of skin cancer. Skin cancer was induced by application of 7,12-dimethylbenz[a]anthracene (DMBA) and croton oil on the dorsal skin of mice. Dorsal skin was removed for estimation of gene and protein expression of Wnt, β-catenin, SMAD, TGF-β, NFκB, TNF-α, IL-4 and IL-10. Part of the skin is stained with hematoxylin/eosin for assessment of cell structure. Treatment of mice with IWP12 completely blocked Wnt in skin cancer mice without affecting the control mice. Skin of tumorigenic mice showed marked skin hyperkeratosis, parakeratosis, acanthosis and dysplasia. Treatment with IWP12 markedly attenuated epidermal atypia and hyperplasia. In addition, IWP12 reduced expression of β-catenin, SMAD, TGF-β, NFκB and TNF-α associated with increase in the expression of IL-4 and IL-10. In conclusion, blocking Wnt production ameliorated skin cancer via blocking pro-inflammatory cytokines and enhancing the anti-inflammatory cytokines. Moreover, blocking Wnt attenuated skin cancer-induced activation of fibrosis pathway.
Insights
Blocking the Wnt pathway with IWP12 effectively treats skin cancer in mice. This approach reduces inflammation and fibrosis by modulating key signaling molecules and cytokines, offering a promising therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- The Wnt pathway is crucial for cancer cell metabolism, promoting inflammation via NFκB and fibrosis via TGF-β.
- Targeting the Wnt pathway presents a potential therapeutic strategy for various cancers.
Purpose of the Study:
- To investigate the therapeutic effects of blocking the Wnt pathway using IWP12 in a mouse model of skin cancer.
- To assess the impact of IWP12 on skin cancer-induced inflammation and fibrosis.
Main Methods:
- Skin cancer was induced in mice using 7,12-dimethylbenz[a]anthracene (DMBA) and croton oil.
- Gene and protein expression of Wnt signaling components, inflammatory markers (NFκB, TNF-α), and fibrotic markers (SMAD, TGF-β) were analyzed.
- Histopathological analysis using hematoxylin/eosin staining evaluated skin tissue structure.
Main Results:
- IWP12 treatment completely blocked Wnt signaling in skin cancer mice without affecting controls.
- IWP12 significantly attenuated skin hyperkeratosis, parakeratosis, acanthosis, and dysplasia.
- IWP12 reduced the expression of β-catenin, SMAD, TGF-β, NFκB, and TNF-α, while increasing IL-4 and IL-10 expression.
Conclusions:
- Blocking Wnt pathway activation with IWP12 ameliorates skin cancer by inhibiting pro-inflammatory cytokines and enhancing anti-inflammatory cytokines.
- IWP12 treatment effectively reduces skin cancer-induced inflammation and fibrosis, demonstrating its therapeutic potential.
More Related Videos
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Therapeutic Index
Block Diagram Reduction
The first step in this process is the identification and relocation of a branch point. A branch point, where a...

